TWD 78.5
(-29.28%)
Year | Net Income | Net Income Growth |
---|---|---|
2023 | -51.78 Million TWD | -63.16% |
2022 | -31.73 Million TWD | -41.99% |
2021 | -22.35 Million TWD | -59.99% |
2020 | -13.97 Million TWD | 0.0% |
2019 | - TWD | 0.0% |
Year | Net Income | Net Income Growth |
---|---|---|
2024 Q2 | -31.41 Million TWD | -0.55% |
2023 FY | -51.78 Million TWD | -63.16% |
2023 Q4 | -31.24 Million TWD | -52.15% |
2023 Q2 | -20.53 Million TWD | -7.3% |
2022 Q4 | -19.13 Million TWD | 0.0% |
2022 FY | -31.73 Million TWD | -41.99% |
2021 FY | -22.35 Million TWD | -59.99% |
2020 FY | -13.97 Million TWD | 0.0% |
2019 FY | - TWD | 0.0% |
Name | Net Income | Net Income Difference |
---|---|---|
SYN-TECH Chem. & Pharm. Co., Ltd. | 251.01 Million TWD | 120.629% |
Level Biotechnology Inc. | 62.9 Million TWD | 182.318% |
Sagittarius Life Science Corp | -55.03 Million TWD | 5.918% |
NeoCore Technology Co., Ltd. | -64.64 Million TWD | 19.898% |
TaiMed Biologics Inc. | -194.81 Million TWD | 73.419% |
GlycoNex Incorporation | -178.36 Million TWD | 70.968% |
VBI | -6.6 Million TWD | -684.457% |
GeneReach Biotechnology Corp. | -166.27 Million TWD | 68.857% |
Taiwan Advance Bio-Pharmaceutical Inc. | -10.68 Million TWD | -384.759% |
SynCore Biotechnology Co.,Ltd | -38.17 Million TWD | -35.654% |
Genomics BioSci & Tech. Co.,Ltd. | -168.06 Million TWD | 69.189% |
Visgeneer Inc. | -19.58 Million TWD | -164.342% |
Mycenax Biotech Inc. | -682.84 Million TWD | 92.417% |
Sunmax Biotechnology Co., Ltd. | 625.7 Million TWD | 108.276% |
G&E Herbal Biotechnology Co., Ltd. | 72.4 Million TWD | 171.522% |
Neith Corporation | -40.03 Million TWD | -29.348% |
Medigen Vaccine Biologics Corporation | -1.15 Billion TWD | 95.535% |
TaiwanJ Pharmaceuticals Co., Ltd. | -6.04 Million TWD | -756.325% |
Enimmune corporation | -223.74 Million TWD | 76.856% |
TaiRx, Inc. | -212.29 Million TWD | 75.608% |
CHO Pharma, Inc. | -306.08 Million TWD | 83.083% |
EirGenix Inc. | -915.2 Million TWD | 94.342% |
BioLASCO Taiwan Co., Ltd. | 49.74 Million TWD | 204.099% |
Sunny Pharmtech Inc. | -63.32 Million TWD | 18.222% |
Lin BioScience, Inc. | -687.19 Million TWD | 92.465% |
BioGend Therapeutics Co., Ltd. | -156.32 Million TWD | 66.875% |
Feng Chi Biotech Corp. | 22.79 Million TWD | 327.194% |
Bio Preventive Medicine Corp. | -73.28 Million TWD | 29.342% |
Lukas Biomedical Inc. | -47.35 Million TWD | -9.353% |
RBC Bioscience Corporation | 6.43 Million TWD | 905.319% |
BiOptic Inc. | 37.74 Million TWD | 237.182% |
BRIM Biotechnology, Inc. | -688.02 Million TWD | 92.474% |
Shine-On BioMedical Co.,Ltd. | -37.16 Million TWD | -39.33% |
Great Novel Therapeutics Biotech & Medicals | -61.54 Million TWD | 15.856% |
Syngen Biotech Co.,Ltd. | 274.82 Million TWD | 118.842% |
Advagene Biopharma Co., Ltd. | -92.11 Million TWD | 43.782% |
NaviFUS Corp. | -65.72 Million TWD | 21.219% |
Gwo Xi Stem Cell Applied Technology Co. , Ltd | -88.08 Million TWD | 41.216% |
Sinew Pharma Inc. | -170.92 Million TWD | 69.704% |
Andros Pharmaceuticals Co.,Ltd | -68.15 Million TWD | 24.028% |
Greenyn Biotechnology Co., Ltd | 130.66 Million TWD | 139.63% |
Lumosa Therapeutics Co., Ltd. | -238.04 Million TWD | 78.247% |
AP Biosciences Inc | -339.29 Million TWD | 84.738% |
Medigen Biotechnology Corp. | -561.29 Million TWD | 90.775% |
3D Global Biotech Inc. | -57.95 Million TWD | 10.645% |
Pharmosa Biopharm Inc. | 8.45 Million TWD | 712.37% |
Intech Biopharm Corporation | -337.98 Million TWD | 84.679% |
Oneness Biotech Co., Ltd. | -1.31 Billion TWD | 96.056% |
Eusol Biotech Co.,Ltd. | -51.61 Million TWD | -0.327% |
TWi Biotechnology, Inc. | -170.68 Million TWD | 69.662% |
Ever Supreme Bio Technology Co., Ltd | 539.39 Million TWD | 109.6% |
TCI GENE Inc. | 11.67 Million TWD | 543.605% |
MegaPro Biomedical Co., Ltd | -127.54 Million TWD | 59.402% |
Senhwa Biosciences, Inc. | -296.3 Million TWD | 82.524% |
Taiwan Bio Therapeutics Co., Ltd | -217.51 Million TWD | 76.193% |
NatureWise Biotech & Medicals Corporation | 10.12 Million TWD | 611.68% |
PharmaEngine, Inc. | 274.65 Million TWD | 118.854% |
Savior Lifetec Corporation | 30.03 Million TWD | 272.434% |
TaiGen Biopharmaceuticals Holdings Limited | 136.73 Million TWD | 137.871% |
OBI Pharma, Inc. | -1.04 Billion TWD | 95.052% |
Meribank Biotech Co., Ltd | -125.34 Million TWD | 58.689% |
Acepodia, Inc. | -817.31 Million TWD | 93.664% |
Caliway Biopharmaceuticals Co., Ltd. | -488.45 Million TWD | 89.399% |